Find uplifting stories about heroes, innovations, and solutions
44 results for "merck"
A breakthrough cholesterol pill from Merck just proved it works as well as injections, making life-saving heart disease treatment easier than ever. With heart disease still America's number one killer for a century, this daily pill could help 70% of patients who aren't reaching their cholesterol goals.
Patient advocates from 30 countries are already calling on Merck to ensure its promising monthly HIV prevention pill reaches everyone who needs it. The treatment could revolutionize HIV prevention by replacing daily pills with a once-a-month option.
Millions with high cholesterol just got a simpler treatment option. The FDA approved Merck's new pill that could replace regular injections for heart disease prevention.
A promising HIV prevention pill could be manufactured for less than $5 per patient annually, making protection accessible to millions worldwide. The experimental drug shows results within 24 hours and could transform HIV prevention in low-income countries.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
Merck and Mayo Clinic are combining artificial intelligence with real patient data to speed up the discovery of breakthrough medicines. The collaboration aims to make drug development faster, smarter, and more likely to succeed.
The FDA just approved a powerful new combination therapy that could help thousands of kidney cancer patients stay cancer-free after surgery. Merck's belzutifan paired with Keytruda offers new hope for those at high risk of their cancer returning.
Forty talented Ghanaian girls just received scholarships that will cover their education all the way through graduation, removing financial barriers to their dreams. The Merck Foundation's Educating Linda program has now supported over 1,500 schoolgirls across 21 African countries.
Major pharmaceutical companies are replacing animal testing with cutting-edge human tissue models that predict drug safety more accurately. Merck KGaA plans to eliminate most animal tests within a decade.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
Forty bright Ghanaian schoolgirls just received scholarships that will cover their education all the way through graduation, removing financial barriers that too often end young women's dreams. The program, part of a larger effort that's already supported over 1,500 girls across 21 African countries, is proving that investing in girls transforms entire communities.
A new combination drug therapy reduced lung cancer progression by 65% in a groundbreaking study, offering fresh hope for patients facing this deadly disease. The treatment marks the first successful pairing of two powerful cancer-fighting approaches in previously untreated patients.
A newly approved topical solution gives U.S. cattle producers their first effective tool to prevent and treat New World screwworm infestations that threaten the agricultural industry. The pour-on treatment also controls cattle fever tick, offering ranchers multiple protections in one application.
A groundbreaking once-daily pill just won FDA approval that drops dangerous cholesterol to levels statins can't touch, and it costs a fraction of existing alternatives. For millions at risk of heart disease, this could be the game changer doctors have been waiting for.
A groundbreaking partnership has trained 141 doctors and nurses across 27 African countries in specialized cancer care, addressing a critical shortage of oncology experts. The program equips healthcare workers with skills to diagnose, treat, and manage cancer in communities that desperately need them.
A groundbreaking mRNA therapy reduced melanoma recurrence or death by 49% over five years when combined with immunotherapy. The personalized vaccine teaches patients' immune systems to recognize and attack their specific cancer cells.
Sixteen major pharmaceutical companies agreed to cut prescription drug prices for Americans through a new discount platform called TrumpRx. Popular medications including weight-loss drugs, diabetes treatments, and asthma inhalers will now cost significantly less for millions of consumers.
A groundbreaking single-tablet treatment for HIV just won FDA approval, making it easier for patients to stay on track with their medication. The new pill combines two drugs into one daily dose for people already managing the virus successfully.
A breakthrough treatment for aggressive endometrial cancer significantly extended survival in clinical trials, offering hope for patients who've run out of options. This marks the first time any drug of its kind has outperformed chemotherapy for this increasingly deadly cancer.
A Boston patient just received the world's first cellular reprogramming injection designed to reverse aging in the human body. The groundbreaking trial could transform how we treat age-related diseases.
Showing 20 of 44